Autoimmune liver disease.

Autoimmune liver disease. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Autoimmune liver disease. Abstract Text:

PURPOSE OF REVIEW: To review studies that improve the diagnosis and treatment of autoimmune hepatitis and extend understanding of its pathogenic mechanisms. RECENT FINDINGS: Black patients have more advanced disease and poorer outcomes than white patients. Genome-wide DNA microsatellite techniques have identified multiple regions that may confer susceptibility or resistance to the disease. Preferential inactivation of one parentally-derived X chromosome may favor autoreactivity in women. Acute and chronic hepatitis of undetermined cause can respond to corticosteroid therapy and represent autoantibody-negative autoimmune hepatitis. Outcomes can be improved by continuing therapies until resolution of all features and by early identification of problematic patients with the Model for End Stage Liver Disease. Serum levels of B-cell activating factor correlate with laboratory indices of liver injury. Tacrolimus and mycophenolate mofetil are promising therapies for problematic patients, and the antigenic targets of atypical antibodies to liver/kidney microsome may lead to diagnostic tests for de-novo autoimmune hepatitis after liver transplantation. SUMMARY: Ethnic background and genetic predisposition affect the occurrence and outcome of autoimmune hepatitis. Susceptibility and resistance factors across the human genome underscore the genetic complexity of the disease. Outcomes can be improved by better use of current regimens and further evaluation of action-specific immunosuppressive agents.

Autoimmune liver disease. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Autoimmune liver disease. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Current opinion in gastroenterology

VOLUME: 24

Page Numbers: 298-305

Journal Abbreviation: Curr. Opin. Gastroenterol.

ISSN: 1531-7056

DAY: 14

MONTH: May

YEAR: 2008

Autoimmune liver disease. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8506887

Autoimmune liver disease. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Autoimmune liver disease. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Autoimmune liver disease.

AFFILIATION: Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA. czaja.albert@mayo.edu

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Curr Opin Gastroenterol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Autoimmune liver disease Related Publications

• A prospective investigation of major depressive disorder and comorbidity in abused and neglected children grown up.
• Age differences in life satisfaction as a function of discrepancy between real and ideal self concepts.
• Autoimmune liver disease.
• CNS lymphomatoid granulomatosis in AIDS: CT and MR appearances.
• Cell signaling in oxidative stress-induced liver injury.
• Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly.
• Compensatory mechanisms and the type of injury determine the fate of cells with impaired macroautophagy.
• Employment opportunities for older adults: engineering design and research issues.
• Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease.
• Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis.
• Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis.
• HLA DQ gene dosage and risk and severity of celiac disease.
• Loss of macroautophagy promotes or prevents fibroblast apoptosis depending on the death stimulus.
• Predictive factors for hepatocellular carcinoma in type 1 autoimmune hepatitis.
• Regulation of hepatocyte apoptosis by oxidative stress.
• Safety issues in the management of autoimmune hepatitis.
• The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's disease.
• [Binge eating and obesity in children]
• [Statistical analysis of some size parameters of haversian systems in femoral, ground transverse sections in man and animals (author's transl)]